This Thursday, May 26th, 2022, join Lumira Ventures Principal, Nikhil Thatte as he leads the Investing in Life Sciences from Health Tech to Therapeutics: Driving Impact and Producing Sizable Returns panel discussion. Nikhil along with four other leading US and Canadian healthcare investors (Paulina Hill, Sanofi Ventures; Cedric Bisson, Teralys Capital Inc; Noel Brown, RBC Capital Markets; and Gordon McCauley, adMare Bioinnovations), will speak on the transformational past decade for the healthcare sector, their past successes, what’s next and what it will mean for investors in the sector, patients, and healthcare systems globally at Invest Canada 2022.
Over the past decade we saw sector wide changes in the healthcare ecosystem; investors striving for more from their investments – changes in the healthcare sector seeking performance and impact, and the optimization of patient care with the adoption of new technologies and novel treatments being developed and approached at faster rates and for a broader set of diseases than ever before. We continue to see these advances further highlighted during the pandemic as healthcare delivery was streamlined and global collaboration led to a pace of innovation, development, and regulatory approval that was previously unfathomable. The significant gaps in the health care continuum and the thousands of diseases still seeking cures, mean that the door is wide open for impactful investing in next-generation innovations in the areas of biotherapeutics, medical devices, digital health, and healthcare IT with the goal of profoundly transforming the care paradigm.